title: Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
authors.affiliation: Division of Pediatric Gastroenterology and Nutrition, North Shore-Long Island Jewish Health System, New York University School of Medicine, Manhasset, New York, USA. EIOFEL@lij.edu
authors.forename: Elizaveta
authors.initials: E
authors.lastname: Iofel
authors.forename: Anupama
authors.initials: A
authors.lastname: Chawla
authors.forename: Fredric
authors.initials: F
authors.lastname: Daum
authors.forename: James
authors.initials: J
authors.lastname: Markowitz
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003967:Diarrhea / Q000209:etiology; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D019804:Mesalamine / Q000009:adverse effects*; D012460:Sulfasalazine / Q000009:adverse effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D019804:Mesalamine